# Treatment of ITP With Rituximab and / or Accutane

> **NCT02757196** · PHASE2 · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 112 (estimated)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** Rituximab plus methylprednisolone
- **DRUG:** methylprednisolone

## Key facts

- **NCT ID:** NCT02757196
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2016-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02757196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02757196, "Treatment of ITP With Rituximab and / or Accutane". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02757196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*